Zeskind Benjamin J. 4
4 · Immuneering Corp · Filed Mar 1, 2022
Insider Transaction Report
Form 4
Immuneering CorpIMRX
Zeskind Benjamin J.
DirectorPRESIDENT AND CEO
Transactions
- Exercise/Conversion
Stock Option
2022-02-28−2,000→ 208,000 totalExercise: $3.01Exp: 2029-12-15→ Class A Common Stock (2,000 underlying) - Exercise/Conversion
Class A Common Stock
2022-02-28$3.01/sh+2,000$6,020→ 2,254,352 total
Holdings
- 894,927(indirect: See Foonote)
Class A Common Stock
Footnotes (2)
- [F1]Held by the Benjamin J. Zeskind 2020 Family Trust, where Lisa Schwartz, Dr. Zeskind's spouse, serves as sole trustee.
- [F2]The option has fully vested and is currently exercisable.